How do you calculate the positive likelihood ratio?
Positive likelihood ratio = sensitivity / (1 - specificity)
Describe what percentage of people like within 1, 2, and 3 standard deviations from the mean
Describe the positive predictive value and how to calculate it
Describe the negative predictive value and how to calculate it
Describe sensitivity and how to calculate it
Describe specificity and how to calculate it
What is the value of a likelihood ratio?
Describe the positive likelihood ratio and how to calculate it
Describe the negative likelihood ratio and how to calculate it
What is the difference between incidence and prevalence?
- Prevalence is a cross section in time e.g. point prevalence studies
What is the most important property of a screening test?
Sensitivity
What are the criteria for a screening test (Wilson’s criteria)?
What is the relative risk and how do you calculate it?
What is the odds ratio and how do you calculate it?
What is the absolute risk and how do you calculate it?
What is the number needed to treat and how do you calculate it?
What is the number needed to harm and how do you calculate it?
What is a type 1 error?
= alpha error = false positive = p value
What is a type 2 error?
= beta error = false negative
- failing to reject the null hypothesis when it should have been rejected
What increases the risk of a type 2 error (rejecting a good treatment)?
= beta error = false negative
= failing to reject the null hypothesis when it should have been rejected
= risk when the study is underpowered
What is the power of a study and what is it determined by?
Describe the phases of drug design
Stage 0 - first in human studies, looks at pharmacokinetics and pharmacodynamics in humans, single sub-therapeutic dose given
Stage 1 - safety, healthy volunteers, determines safe dosing ranges, identify adverse events
Stage 2 - safety and efficacy (placebo), dosing requirements. Some combine stage 1 + 2
Stage 3 - confirmation of safety and efficacy, compare to active treatment (assess gold standard), RCT, requires approval from FDA
Stage 4 - continual pharmacovigilance (post marketing surveillance), new uses/populations, children, larger populations but less controlled, longer follow-up, interactions with other meds
What are types of observational studies?
What is the difference between internal and external validity?